AnalystsEric JosephEric Joseph's Stock Forecasts
AnalystsEric Joseph
Analyst Ranking
Bottom 3%
#4455 out of 4560 analysts
Average Return
-19.55%
Win Rate
34%18 out of 53
Risk vs Reward
Poor
Good
Eric Joseph's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Achilles Therapeutics PLCACHL | +85.19% | $16.75 | $2.48 | 2021-04-26 - 2022-04-25 | Strong Sell |
Momenta Pharmaceuticals IncMNTA | +81.59% | $28.90 | $52.48 | 2020-01-15 - 2020-09-30 | Strong Buy |
Monte Rosa Therapeutics IncGLUE | +77.28% | $3.13 | $5.54 | 2023-10-19 - 2024-04-23 | Strong Buy |
Novavax IncNVAX | +69.65% | $22.44 | $6.81 | 2022-09-22 - 2023-09-21 | Strong Sell |
Revolution Medicines IncRVMD | +68.73% | $21.49 | $36.26 | 2023-11-07 - 2024-04-23 | Strong Buy |
Eric Joseph Analyst Color
Get additional color on Eric Joseph's coverage of popular stocks
Eric Joseph's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tg Therapeutics IncTGTX | 3 | Strong Buy | $25.00 | +75.44% | Reiterates | 6 days ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Buy | $50.00 | +111.24% | Maintains | 2 months ago |
Vir Biotechnology IncVIR | 3 | Hold | $10.00 | +23.00% | Maintains | 2 months ago |
Kymera Therapeutics IncKYMR | 2 | Strong Buy | $47.00 | +31.62% | Maintains | 2 months ago |
Enanta Pharmaceuticals IncENTA | 3 | Strong Sell | $11.00 | -16.35% | Maintains | 3 months ago |
C4 Therapeutics IncCCCC | 4 | Hold | $6.00 | -13.04% | Upgrades | 3 months ago |
Beam Therapeutics IncBEAM | 2 | Strong Buy | $40.00 | +70.43% | Upgrades | 3 months ago |
Livent CorpLTHM | 2 | Hold | $15.00 | -9.15% | Maintains | 5 months ago |
Recursion Pharmaceuticals IncRXRX | 2 | Hold | $10.00 | +29.87% | Maintains | 5 months ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $39.00 | +7.56% | Maintains | 6 months ago |
Prime Medicine IncPRME | 2 | Strong Buy | $26.00 | +441.67% | Maintains | 6 months ago |
Monte Rosa Therapeutics IncGLUE | 2 | Strong Buy | $11.00 | +98.56% | Maintains | 6 months ago |
Akero Therapeutics IncAKRO | 2 | Strong Buy | $41.00 | +95.24% | Maintains | 6 months ago |
Lyell Immunopharma IncLYEL | 1 | Hold | $5.00 | +104.92% | Downgrades | 8 months ago |
Century Therapeutics IncIPSC | 2 | Hold | $5.00 | +59.74% | Downgrades | 8 months ago |
Pliant Therapeutics IncPLRX | 3 | Strong Buy | $48.00 | +283.39% | Maintains | 8 months ago |
Terns Pharmaceuticals IncTERN | 6 | Hold | $11.00 | +134.54% | Maintains | 8 months ago |
Igm Biosciences IncIGMS | 3 | Hold | $19.00 | +146.75% | Maintains | a year ago |
Hillevax IncHLVX | 2 | Strong Buy | $22.00 | +71.74% | Maintains | a year ago |
Ptc Therapeutics IncPTCT | 3 | Strong Buy | $64.00 | +151.87% | Maintains | a year ago |
Bluebird Bio IncBLUE | 1 | Strong Buy | $7.00 | +620.91% | Initiates Coverage On | a year ago |
Relay Therapeutics IncRLAY | 3 | Strong Buy | $29.00 | N/A | Maintains | a year ago |
Atea Pharmaceuticals IncAVIR | 4 | Hold | $8.00 | N/A | Maintains | a year ago |
Nurix Therapeutics IncNRIX | 4 | Strong Buy | $36.00 | N/A | Maintains | a year ago |
Mirati Therapeutics IncMRTX | 1 | Hold | $65.00 | N/A | Downgrades | a year ago |
Surrozen IncSRZN | 2 | Strong Sell | N/A | N/A | Downgrades | a year ago |
Novavax IncNVAX | 5 | Strong Sell | $27.00 | N/A | Downgrades | 2 years ago |
Karyopharm Therapeutics IncKPTI | 2 | Hold | $8.00 | N/A | Upgrades | 2 years ago |
Aligos Therapeutics IncALGS | 1 | Hold | $12.00 | N/A | Downgrades | 2 years ago |
Omeros CorpOMER | 2 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Hold | $120.00 | N/A | Downgrades | 3 years ago |
Verve Therapeutics IncVERV | 1 | Hold | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Achilles Therapeutics PLCACHL | 1 | Strong Sell | $11.00 | N/A | Initiates Coverage On | 3 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | $153.00 | N/A | Maintains | 3 years ago |
Autolus Therapeutics PLCAUTL | 2 | Hold | $9.00 | N/A | Downgrades | 3 years ago |
Akebia Therapeutics IncAKBA | 1 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Urovant Sciences LtdUROV | 2 | Hold | $16.00 | N/A | Downgrades | 3 years ago |
Five Prime Therapeutics IncFPRX | 2 | Hold | $14.00 | N/A | Upgrades | 3 years ago |
Obseva SaOBSVF | 1 | Hold | $5.00 | N/A | Downgrades | 4 years ago |
Black Diamond Therapeutics IncBDTX | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 4 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Strong Buy | $30.00 | N/A | Upgrades | 4 years ago |
Ironwood Pharmaceuticals IncIRWD | 2 | Hold | $13.00 | N/A | Upgrades | 5 years ago |
Sangamo Therapeutics IncSGMO | 2 | Hold | $11.00 | N/A | Maintains | 5 years ago |
Opko Health IncOPK | 2 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.